Absence of severe COVID-19 in patients with clonal mast cells activation disorders: effective anti-SARS-CoV-2 immune response.
J. Rossignol, A. Ouedrani, C. Bulai-Livideanu, S. Barete, L. Terriou, D. Launay, R. Lemal, C. Greco, L. Frenzel, C. Meni, C. Bodemere-Skandalis, L. Polivka, A.-F. Collange, H. Hachichi, S. Bouzourine, , Mania
The paper investigates the immune response in patients with clonal mast cells activation disorders (cMCADs) during SARS-CoV-2 infection and finds no severe COVID-19 cases and robust anti-viral immunity.
bioRxiv · Sep 1, 2021 · PreprintImmunology